Aton Pharma, Inc. (Acquired by Merck & Co., Inc.)

15 articles about Aton Pharma, Inc. (Acquired by Merck & Co., Inc.)

• Valeant Pharmaceuticals International Completes Acquisition of Aton Pharma, Inc.

  5/27/2010

• Valeant Pharmaceuticals International to Acquire Aton Pharma, Inc. for About $318 Million

  5/3/2010

• Aton Pharma, Inc.: Study of Lacrisert(R) Dry Eye Insert

  5/3/2010

• Bristol-Myers Squibb Company Parkinsons's Drug Acquired by Aton Pharma, Inc.

  4/26/2010

• Aton Pharma, Inc. Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution

  3/9/2010

• Aton Pharma, Inc. Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations

  2/16/2010

• Aton Pharma, Inc. Announces Michael H. Richardson to Head Orphan Drug Division

  2/9/2010

• Aton Pharma, Inc. Study of Lacrisert(R) Dry Eye Insert Published in The Ocular Surface

  8/19/2009

• Aton Pharma, Inc. Release: Association for Research in Vision & Ophthalmology, AOS: Large Study of Lacrisert(R) Dry Eye Insert; Patients Experience Significant Improvement in Ocular Surface Disease and Quality of Life

  5/4/2009

• Aton Pharma, Inc. Announces Large Study of Lacrisert(R) Dry Eye Insert

  5/4/2009

• Aton Pharma, Inc. Release: Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye

  11/10/2008

• Aton Pharma, Inc. Announces Distribution Partnership in the Asia Pacific Region

  5/21/2008

• Aton Pharma, Inc. Announces Distribution Partnership in Brazil

  5/12/2008

• Aton Pharma, Inc. Announces the Appointment of Dr. Fred Eshelman to Management Board

  2/25/2008

• Aton Pharma, Inc. Introduces Expanded Distribution of Lacrisert(R)

  1/24/2008